Table 4. Relationship between ING5 expression and clinicopathological features of the triple-negative breast cancer.

Clinicopathological features		Nuclear ING5 expression						Cytoplasmic ING5 expression
	n	–	+	++	+++	PR(%)	p	–	+	++	+++	PR(%)	p
Age (years)
< 45	29	3	8	8	10	89.7	0.444	11	16	2	0	62.1	0.044
≥ 45	63	7	20	21	15	88.9		17	28	13	5	73.0
Tumor size (cm)
< 2.5	5	0	1	1	3	100.0	0.251	2	1	1	1	60.0	0.907
≥ 2.5	10	1	4	2	3	90.0		2	4	1	3	80.0
Lymph node metastasis
+	38	6	11	10	11	84.2	0.439	16	15	3	4	57.9	0.107
–	53	4	16	19	14	92.5		11	29	12	1	79.2
Distant metastasis
+	10	2	5	3	0	80.0	0.026	3	6	1	0	70.0	0.605
–	82	9	22	26	25	89.0		25	38	14	5	69.5
TNM staging
I–II	67	8	16	20	23	88.1	0.056	21	29	14	3	68.7	0.661
III–IV	24	2	11	9	3	91.7		7	14	1	2	70.8

PR, positive rate; TNM, tumor node metastasis.